ATE219354T1 - Verbesserte kristallstrukturen - Google Patents
Verbesserte kristallstrukturenInfo
- Publication number
- ATE219354T1 ATE219354T1 AT99917842T AT99917842T ATE219354T1 AT E219354 T1 ATE219354 T1 AT E219354T1 AT 99917842 T AT99917842 T AT 99917842T AT 99917842 T AT99917842 T AT 99917842T AT E219354 T1 ATE219354 T1 AT E219354T1
- Authority
- AT
- Austria
- Prior art keywords
- crystals
- crystal structures
- improved crystal
- compositions
- lactose
- Prior art date
Links
- 239000013078 crystal Substances 0.000 title abstract 4
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 abstract 1
- WSVLPVUVIUVCRA-KPKNDVKVSA-N Alpha-lactose monohydrate Chemical compound O.O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O WSVLPVUVIUVCRA-KPKNDVKVSA-N 0.000 abstract 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 abstract 1
- GIIZNNXWQWCKIB-UHFFFAOYSA-N Serevent Chemical compound C1=C(O)C(CO)=CC(C(O)CNCCCCCCOCCCCC=2C=CC=CC=2)=C1 GIIZNNXWQWCKIB-UHFFFAOYSA-N 0.000 abstract 1
- NDAUXUAQIAJITI-UHFFFAOYSA-N albuterol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-UHFFFAOYSA-N 0.000 abstract 1
- 229960000289 fluticasone propionate Drugs 0.000 abstract 1
- WMWTYOKRWGGJOA-CENSZEJFSA-N fluticasone propionate Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(OC(=O)CC)[C@@]2(C)C[C@@H]1O WMWTYOKRWGGJOA-CENSZEJFSA-N 0.000 abstract 1
- 229960001361 ipratropium bromide Drugs 0.000 abstract 1
- KEWHKYJURDBRMN-ZEODDXGYSA-M ipratropium bromide hydrate Chemical compound O.[Br-].O([C@H]1C[C@H]2CC[C@@H](C1)[N@@+]2(C)C(C)C)C(=O)C(CO)C1=CC=CC=C1 KEWHKYJURDBRMN-ZEODDXGYSA-M 0.000 abstract 1
- 229960001375 lactose Drugs 0.000 abstract 1
- 239000008101 lactose Substances 0.000 abstract 1
- 229960001021 lactose monohydrate Drugs 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229960005018 salmeterol xinafoate Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C07D451/06—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/04—Disaccharides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Pulmonology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Otolaryngology (AREA)
- Medicinal Preparation (AREA)
- Glass Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Liquid Crystal Substances (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9806477.7A GB9806477D0 (en) | 1998-03-26 | 1998-03-26 | Improved crystals |
| PCT/EP1999/001966 WO1999048475A1 (en) | 1998-03-26 | 1999-03-24 | Improved crystal structure |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE219354T1 true ATE219354T1 (de) | 2002-07-15 |
Family
ID=10829300
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99917842T ATE219354T1 (de) | 1998-03-26 | 1999-03-24 | Verbesserte kristallstrukturen |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6875449B1 (de) |
| EP (1) | EP1067903B1 (de) |
| JP (1) | JP4312380B2 (de) |
| AT (1) | ATE219354T1 (de) |
| AU (1) | AU3598199A (de) |
| CA (1) | CA2325551A1 (de) |
| DE (1) | DE69901895T2 (de) |
| ES (1) | ES2178422T3 (de) |
| GB (1) | GB9806477D0 (de) |
| WO (1) | WO1999048475A1 (de) |
| ZA (1) | ZA200005032B (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0016040D0 (en) * | 2000-06-29 | 2000-08-23 | Glaxo Group Ltd | Novel process for preparing crystalline particles |
| EP1416990A1 (de) * | 2001-08-09 | 2004-05-12 | Glaxo Group Limited | Inhalator mit einer pharmazeutischen zusammensetzung |
| MX2007009656A (es) | 2005-02-10 | 2007-11-07 | Glaxo Group Ltd | Proceso para elaborar lactosa utilizando tecnicas de clasificacion previa y formulaciones farmaceuticas formadas de la misma. |
| DE102005009194B4 (de) * | 2005-03-01 | 2006-12-14 | Hpp-Hommel Pharmaceuticals Production Gmbh | Verfahren zur Herstellung von polymorph stabilem Triamcinolonacetonid |
| GB0617171D0 (en) * | 2006-08-31 | 2006-10-11 | Generics Uk Ltd | Novel compositions and methods |
| IL186290A0 (en) * | 2007-09-25 | 2008-01-20 | Medimop Medical Projects Ltd | Liquid drug delivery devices for use with syringe having widened distal tip |
| CN101239996B (zh) * | 2008-01-04 | 2010-10-27 | 华南理工大学 | 一种高剪切力微晶乳糖制备方法 |
| WO2010002712A2 (en) * | 2008-06-30 | 2010-01-07 | 3M Innovative Properties Company | Method of crystallization |
| US9326538B2 (en) | 2010-04-07 | 2016-05-03 | Kraft Foods Group Brands Llc | Intermediate moisture bar using a dairy-based binder |
| US9232807B2 (en) | 2011-09-30 | 2016-01-12 | Kraft Foods Group Brands Llc | Dairy-based foods having high levels of lactose |
| US8765725B2 (en) | 2012-05-08 | 2014-07-01 | Aciex Therapeutics, Inc. | Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof |
| EP2847207B1 (de) | 2012-05-08 | 2019-03-27 | Nicox Ophthalmics, Inc. | Nanokristalle von Fluticasonpropionat |
| US9815865B2 (en) | 2013-01-07 | 2017-11-14 | Nicox Ophthalmics, Inc. | Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof |
| GB201711233D0 (en) | 2017-07-12 | 2017-08-23 | Aston Particle Tech Ltd | Coating method |
| CN113476428B (zh) * | 2021-01-28 | 2022-03-29 | 朗天药业(湖北)有限公司 | 一种吸入用硫酸沙丁胺醇溶液及其制备方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS57134498A (en) * | 1981-02-12 | 1982-08-19 | Hayashibara Biochem Lab Inc | Anhydrous crystalline maltitol and its preparation and use |
| GB9001635D0 (en) * | 1990-01-24 | 1990-03-21 | Ganderton David | Aerosol carriers |
| SE9302777D0 (sv) | 1993-08-27 | 1993-08-27 | Astra Ab | Process for conditioning substances |
| EP0664701B1 (de) * | 1992-10-16 | 1997-09-10 | Glaxo Group Limited | Geschmacksmaskierende zusammensetzungen von ranitidin |
| US5747445A (en) * | 1993-06-24 | 1998-05-05 | Astra Aktiebolag | Therapeutic preparation for inhalation |
| GB9501841D0 (en) | 1995-01-31 | 1995-03-22 | Co Ordinated Drug Dev | Improvements in and relating to carrier particles for use in dry powder inhalers |
| SE9501384D0 (sv) * | 1995-04-13 | 1995-04-13 | Astra Ab | Process for the preparation of respirable particles |
| EP0828495B1 (de) * | 1995-06-01 | 2002-10-30 | G.D. Searle & Co. | Misoprostolhaltige feste stabilisierte dispersionen |
| US6129905A (en) * | 1997-04-21 | 2000-10-10 | Aeropharm Technology, Inc. | Aerosol formulations containing a sugar as a dispersant |
| US6309623B1 (en) * | 1997-09-29 | 2001-10-30 | Inhale Therapeutic Systems, Inc. | Stabilized preparations for use in metered dose inhalers |
| CN1330709A (zh) * | 1998-10-15 | 2002-01-09 | 宝洁公司 | 纳米孔粒状原料与洗涤剂组合物的制备方法 |
-
1998
- 1998-03-26 GB GBGB9806477.7A patent/GB9806477D0/en not_active Ceased
-
1999
- 1999-03-24 US US09/646,111 patent/US6875449B1/en not_active Expired - Lifetime
- 1999-03-24 AU AU35981/99A patent/AU3598199A/en not_active Abandoned
- 1999-03-24 AT AT99917842T patent/ATE219354T1/de not_active IP Right Cessation
- 1999-03-24 WO PCT/EP1999/001966 patent/WO1999048475A1/en not_active Ceased
- 1999-03-24 ES ES99917842T patent/ES2178422T3/es not_active Expired - Lifetime
- 1999-03-24 JP JP2000537525A patent/JP4312380B2/ja not_active Expired - Lifetime
- 1999-03-24 EP EP99917842A patent/EP1067903B1/de not_active Expired - Lifetime
- 1999-03-24 CA CA002325551A patent/CA2325551A1/en not_active Abandoned
- 1999-03-24 DE DE69901895T patent/DE69901895T2/de not_active Expired - Lifetime
-
2000
- 2000-09-20 ZA ZA200005032A patent/ZA200005032B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB9806477D0 (en) | 1998-05-27 |
| CA2325551A1 (en) | 1999-09-30 |
| DE69901895T2 (de) | 2002-12-19 |
| EP1067903A1 (de) | 2001-01-17 |
| ZA200005032B (en) | 2001-09-20 |
| EP1067903B1 (de) | 2002-06-19 |
| ES2178422T3 (es) | 2002-12-16 |
| WO1999048475A1 (en) | 1999-09-30 |
| AU3598199A (en) | 1999-10-18 |
| JP2002507471A (ja) | 2002-03-12 |
| DE69901895D1 (de) | 2002-07-25 |
| US6875449B1 (en) | 2005-04-05 |
| JP4312380B2 (ja) | 2009-08-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69901895D1 (de) | Verbesserte kristallstrukturen | |
| USD518298S1 (en) | Paper product | |
| USD490707S1 (en) | Prescription bottle cap | |
| MA25842A1 (fr) | Monohydrate cristallin, procede pour sa fabrication et son utilisation pour la fabrication d'un medicament. | |
| BR0301017A (pt) | Cristalização graduada de acabamentos de contêineres | |
| IL152470A0 (en) | Pharmaceutical composition comprising micronised formoterol and micronised glucocorticosteroid | |
| DK1007017T4 (da) | Formulering af budesonid/formoterol til inhalering, som har en hældebulkdensitet på 0,30 til 0,36 g/ml, en fremgangsmåde til fremstilling af formuleringen og anvendelsen deraf | |
| AU2002213975A1 (en) | Novel anticholinergic agents that can be used as medicaments and method for the production thereof | |
| EP1508586A4 (de) | Hydroxyapatit-verbundwerkstoff, herstellungsverfahren dafür und diesen enthaltenes medizinisches material | |
| USD375914S (en) | Diamond | |
| FR2808470B1 (fr) | Film multicouche microporeux respirable a impermeabilite renforcee aux liquides et procede de production | |
| FR2550956B1 (fr) | Procede de purification d'un gaz naturel, pouvant notamment etre integre dans un procede de liquefaction de ce gaz naturel | |
| FR2699370B1 (fr) | Procédé pour la fabrication d'un lait infantile liquide prêt à l'emploi longue conservation et anti-régurgitation, et lait ainsi obtenu. | |
| BR9206100A (pt) | Processo para o isolamento de tubos | |
| USD482799S1 (en) | Glass panel | |
| AU2003240847A1 (en) | Container for tobacco articles and relative production method | |
| USD359704S (en) | Timepiece dial | |
| AU2940400A (en) | Cold-storage material with excellent shape stability and process for producing the same | |
| IL162919A0 (en) | Process for the production of 6.alpha.,9.alpha-difluoro-17.alpha.-(1-oxo-propoxy)-11.bedroxy-16.alpha.-methyl-3-oxo-androst-1,4-diene-17.b | |
| FR2721037B1 (fr) | Mélange pour la fabrication de produits profilés en matière plastique à base de polycaprolactone, plaques et attelles orthopédiques réalisées à partir de ces mélanges. | |
| ID28020A (id) | Senyawa-senyawa sulfonilsianamida tersubstitusi, prose-proses pembuatannya dan penggunaannya sebagai obat | |
| EP1447464A4 (de) | Kristallherstellungsverfahren für galliumoxid-eisen-mischkristall | |
| USD478878S1 (en) | Face panel for a CPU filler board | |
| AU1152800A (en) | Orally applicable therapeutic dosage form which spontaneously disintegrates uponcontact with a liquid and method for producing the same | |
| JPS6110434A (ja) | 掛止突起付ストロ−の製造方法及び装置 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |